Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How do you think they're going to react to >83 months and >18 months improvement? Do you think they might give $NWBO the benefit of the doubt even though these combo trials aren't phase 3 yet? I do...
I believe all 4 RAs will approve DCVax-L in record time. Nice post!
The good news is that all of our eggs are not in the FDA basket.
Oh my god Ex, you know the trial is a success, but you are trying to mislead potential investors. You and your 8 venal market makers are going to fail as the professional community of neurosurgeons are simply going to laugh you and your friends out of town.
Considering what happened on 5/10 it would be a smart move as it would stop the interim walk down prior to approval. After approval they will be able to PR Revenue, additional Approvals, and up listing.
IMO You should hold until at least until after approval and/or a 500% gain.
Not including the wonderful statistical analysis results provided from the trial, given only DCVax's safety record and the fat tail, why would they not approve DCVax-L provided the other available treatments for GBM.
Please provide the links to any articles that challenge the Journal Article that are not authored by an individual that has a prior relationship with Novacure.
I expect you will not forward one link.
If it were not for the 8 Market Makers, DCVax-L would be approved and saving lives. While you would like to blame management for the events on 5/10/22, the longs know what has transpired.
Fortunately, Longs also are aware that DCVax-L will be approved by all 4 RA's eventually and there is nothing the MM can do to stop the approval process.
They better start covering. There is no way this treatment will not be approved at this point.
Yea, BP will nix that proposal.
I don't believe they have any issues. It's just a complex process.
It's never as simple as one would think. Don't forget to add the impact of Covid 19 .
10 Bagger- "NOTE: I’m asking as someone who believes DCVAX will be approved by all 4 RAs and not looking for an argument as to whether management is good or bad"
There is no doubt in my mind that All 4 RA's will Approve DCVax-L. Following Approval and Ramp Up, several other RA's will approve DCVax-L. Wherever they have a patent, it will be rapidly approved. As there are no other treatments that have a robust fat tail.
IMO - Sawston purpose is to establish the procedures and provide a baseline for production cost of DCVax-L. CRL is probably shadowing both. Prior to approval, NWBO and CRL will negotiate the cost for CRL's services. Needless to say FlaskWorks has been integrated into this process.
Another trial would end up with the same fat tail that exceeds the SOC. What would be the point? Delaying treatment to let more people die? You cannot argue with the surviving fat tail.
So, you do not invest any money in any stock market?
If it were not for the 8 market makers DCVax-L would be Approved and patients would have a chance of obtaining 5 year survival. Your Arrogance of delaying this treatment is disgusting.
They really only needed UL approval.
The new short narrative is good data but it will take forever to get approved. Apparently they have not reviewed the JA .
Are you kidding us? All 4 RA's will accelerate approval. Now the Shorts are saying it will be approved but it will take years. BS.
Longs are flying at 35,000 feet looking at the big picture. Holding for approval and beyond! If you really listen to the company, read what's going on with the industry. read the regulatory agency weather balloons, etc, there has been No bad news. The only bad news is contrived BS from the shorts.
He is more in touch with the GBM community than anyone I know. His endorsement is wonderful for NWBO.
To the contrary. I am up 300% and have full faith in management. If it were not for the 8 Market Makers, NWBO would be producing DCVax-L and saving lives. This said, within a short period, DCVax-L will be approved and your employer will be sitting on the park bench with Poor Man.
Show me one five year survivor that boasts of Optune. They should be embarrassed and yank it off the market.
My nephew tried it to no avail. The only thing it did is raise the insurance cost of his fellow coworkers.
The only reason the SP has not risen more than it has is the continued daily manipulation.
HL - The only reason the SP has not risen more than it has is the continued daily manipulation.
The last setback happened almost 10 months ago on May 10, 2022. With the excellent news of a trial achieving statistical significance the SP started to fall even before the news is delivered. No doubt the spoofing worked. No doubt these actions change LP to change her strategy. No doubt it delayed bringing DCVax-L to the Market. No Doubt the 8 Market Makers caused the deaths of many patients by delaying treatment.
With the JA issued supported by 70 doctors there is also no doubt DCVax-L will be approved.
The 8 venal Market Makers can and will go straight to Hell.
Ex- We will win the world series with a Grand Slam in the 10 inning. Just Keep Watching.
It will work and DCVax will be approved.
NWBO's management has our total support and if it was not for the 8 venal market makers DCVax-L would be approved by now and available to the masses
Unfortunately, we are in MANIPULATION AVOIDANCE mode.
Definitely the 9Th inning
I see it as an instant demand. We will see who is correct.
It will depend on when the RA approves the treatment. It will also depend on off label demand. It will be exciting to see this treatment unfold throughout the world.
A potential cure (DCVax) or strapping into the electric chair (Novacure) and waiting for the inevitable. Which would you choose?
Your correct, it's just an illogical Bear Narrative.
If Merck doesn't want a patent extension and improved performance BMY will.
So Merck wants an inferior product to BMY?
LP is committed to bringing DCVax to the market. Are you saying 70 is too old? How old was Founder of KFC when he started the company?
I believe LP wants maintain control over the development of DCvax-L in the UK. If she contracts with CRL for this work, others could take control or influence the approval process. I would not even put it past BP or the MM to buy CRL.